Johns Hopkins Singapore International Medical Centre is a 30-bed licensed medical oncology facility located in Singapore. The facility, joint venture between the National Healthcare Group (NHG) and Johns Hopkins Medicine International (JHMI) is the only fully branded Johns Hopkins facility outside of the United States. The Centre serves the community of Singapore as well as foreign patients primarily from Southeast Asia and Middle East. The Centre provides inpatient and outpatient medical oncology care, medical intensive care, laboratory, hospital and retail pharmacy, general internal medicine and health screenings.
First opened in 2000 as a state-of-the-art oncology medical centre within the National University Hospital, Johns Hopkins Singapore International Medical Centre is now housed in Tan Tock Seng Hospital. The Johns Hopkins Singapore International Medical Centre brings the most up-to-date therapy and new technology to patients with cancer by working in collaboration with researchers such as local experts from National University of Singapore and National University Hospital.
Johns Hopkins Singapore International Medical Centre's services include inpatient care at a private oncology ward, outpatient consultations and chemotherapy, internal medicine consultations/executive health screenings, as well as second opinions on complex medical conditions and consultations with referring physicians for specialty services. We treat a wide range of cancers, including but not limited to Breast, Ovarian, Uterine, Cervical, Lung, Throat, Nasopharynx, Stomach, Liver, Kidney, Colon and Lymphoma.
Johns Hopkins Singapore International Medical Centre is the first private hospital in Singapore to be awarded the Joint Commission International accreditation in August 2004 and reaccredited in Dec 2007.